OTC birth control arrives amid the battle over reproductive rights

Opill will cost $19.99 a month. Democrats are pushing to make it cheaper.

Hand holding a birth control pill with a grenade pin
Opill "marks a pivotal moment in birth control access"
(Image credit: Illustration by Stephen Kelly / Getty Images)

Cheap, easy birth control is arriving in the United States. The country's first over-the-counter birth control pill "will soon become the most effective birth-control method available without a doctor's visit," said The Wall Street Journal. The pill — called Opill, available for $19.99 a month — is a "milestone that reproductive activists have pursued for decades." And it comes amid fierce political battles over reproductive rights in America. 

One might ask why it took so long for OTC birth control to get here. America, after all, follows "more than 100 countries that permit the sale of contraceptive pills without a prescription," said Axios. Whatever the reason for the delay, it's clear that the end of Roe v. Wade in 2022 provided some urgency to the effort: The American College of Obstetricians and Gynecologists argued in recent years that easing access to the pill was "critical so that more people can control their reproductive fates."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us